Document Detail


The role of HIV serostatus disclosure in antiretroviral medication adherence.
MedLine Citation:
PMID:  16721505     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study examined the relationship between HIV serostatus disclosure and adherence to antiretroviral therapy (ART). The study was conducted with 215 HIV-seropositive patients who demonstrated poor adherence (<80%) and who were in serodiscordant relationships. Participants completed self-report measures regarding HIV serostatus disclosure and reasons for missing ART doses, as well as electronic monitoring of ART adherence (MEMS caps). Overall, 19% of the sample reported missing medication doses in the last two months due to concerns regarding serostatus disclosure. Participants who reported greater serostatus disclosure to others demonstrated higher rates of adherence, and this relationship remained after controlling for other explanatory variables. The relationship between disclosure and adherence was not mediated by practical support for adherence from others. Interventions to improve ART adherence should address the role of serostatus disclosure by providing patients with skills to maintain adherence in contexts of non-disclosure and to make informed choices regarding selective disclosure.
Authors:
Michael J Stirratt; Robert H Remien; Anna Smith; Olivia Q Copeland; Curtis Dolezal; Daniel Krieger;
Related Documents :
18439395 - Aids therapy, 3rd edition.
11042835 - Gay and lesbian couples in therapy: perspectives for the contemporary family therapist.
21457495 - Corticosteroids in severe community-acquired pneumonia: the path we choose depends on w...
7744265 - Azt toxicity and aids prophylaxis: is azt beneficial for hiv+ asymptomatic persons with...
20719435 - Anxiety sensitivity, distress tolerance, and discomfort intolerance in relation to copi...
19896815 - The genetics of autoimmune diseases: a networked perspective.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  AIDS and behavior     Volume:  10     ISSN:  1090-7165     ISO Abbreviation:  AIDS Behav     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-08-23     Completed Date:  2006-10-26     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9712133     Medline TA:  AIDS Behav     Country:  United States    
Other Details:
Languages:  eng     Pagination:  483-93     Citation Subset:  IM    
Affiliation:
HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, New York 10032, USA. mjs2114@columbia.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-HIV Agents / therapeutic use*
Female
HIV Infections / drug therapy*,  psychology
HIV Seropositivity / psychology*
Humans
Male
Patient Compliance*
Questionnaires
Self Disclosure*
Social Support
Grant Support
ID/Acronym/Agency:
R01 MH61173/MH/NIMH NIH HHS; T32 MH19139/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Anti-HIV Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk factors related to recurrence in inguinal hernia repair: a retrospective analysis.
Next Document:  Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires f...